4.82
price down icon1.83%   -0.09
after-market 시간 외 거래: 4.58 -0.24 -4.98%
loading
전일 마감가:
$4.91
열려 있는:
$5.01
하루 거래량:
551.82K
Relative Volume:
0.84
시가총액:
$302.63M
수익:
-
순이익/손실:
$-130.41M
주가수익비율:
-2.1518
EPS:
-2.24
순현금흐름:
$-67.76M
1주 성능:
-2.03%
1개월 성능:
+21.11%
6개월 성능:
-37.24%
1년 성능:
+25.85%
1일 변동 폭
Value
$4.66
$5.1079
1주일 범위
Value
$4.66
$5.26
52주 변동 폭
Value
$3.21
$12.40

Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile

Name
명칭
Monte Rosa Therapeutics Inc
Name
전화
617-949-2643
Name
주소
321 HARRISON AVENUE, BOSTON
Name
직원
134
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GLUE's Discussions on Twitter

GLUE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GLUE
Monte Rosa Therapeutics Inc
4.82 302.63M 0 -130.41M -67.76M -2.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.91 114.57B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.68 55.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.78 39.64B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.64B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
264.42 28.55B 3.81B -644.79M -669.77M -6.24

Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-02-15 개시 Wedbush Outperform
2023-01-03 업그레이드 Wells Fargo Equal Weight → Overweight
2022-10-13 개시 UBS Buy
2022-08-15 개시 Jefferies Buy
2022-04-28 개시 Credit Suisse Neutral
2022-02-10 개시 Wells Fargo Equal Weight
2021-10-14 개시 SVB Leerink Mkt Perform
모두보기

Monte Rosa Therapeutics Inc 주식(GLUE)의 최신 뉴스

pulisher
Jun 14, 2025

Monte Rosa gets FDA clearance to begin testing MRT-8102 - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

FMR LLC Reduces Stake in Monte Rosa Therapeutics Inc. - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Reduces Stock Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Monte Rosa’s molecular glue degrader MRT-8102 gains IND clearance for inflammatory conditions - BioWorld MedTech

Jun 11, 2025
pulisher
Jun 11, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stake Boosted by Millennium Management LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Monte Rosa advances novel inflammatory disease treatment By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa Therapeutics Says US FDA Accepts Investigational New Drug Application for MRT-8102 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa Therapeutics (GLUE) Gains as FDA Clears New Drug Tria - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa gets FDA clearance to begin testing MRT-8102 (GLUE) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa Therapeutics (GLUE) Gains FDA Approval for MRT-8102 I - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa Therapeutics Announces FDA Clearance Of Ind Application For Mrt-8102 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Monte Rosa Therapeutics Announces FDA Clearance of IND - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

FDA Clearance: Monte Rosa's Revolutionary NEK7 Drug Could Transform Inflammatory Disease Treatment - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 222.16%: Read This Before Placing a Bet - sharewise

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Takes $180,000 Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Sold by Jane Street Group LLC - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Takes Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 08, 2025
pulisher
Jun 04, 2025

6,231 Shares in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Acquired by BNP Paribas Financial Markets - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Buys New Shares in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Buys 6,633 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 02, 2025
pulisher
May 28, 2025

CDK2 degradation inducers disclosed in Monte Rosa patent - BioWorld MedTech

May 28, 2025
pulisher
May 28, 2025

Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Monte Rosa CEO Reveals Latest Molecular Glue Degrader Progress at Major Healthcare Conference - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Analyzing Monte Rosa Therapeutics (NASDAQ:GLUE) and Aptose Biosciences (NASDAQ:APTO) - Defense World

May 27, 2025
pulisher
May 26, 2025

D. E. Shaw & Co. Inc. Raises Stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 26, 2025
pulisher
May 25, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Holdings Increased by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 24, 2025

Revenues Working Against Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) Share Price Following 26% Dive - simplywall.st

May 24, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Has $1.01 Million Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 16, 2025
pulisher
May 15, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stake Increased by Tower Research Capital LLC TRC - Defense World

May 15, 2025
pulisher
May 10, 2025

Results: Monte Rosa Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

May 10, 2025
pulisher
May 09, 2025

Monte Rosa Therapeutics Inc (GLUE)’s Day in Review: Closing at 4.22, Up by 9.61 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Monte Rosa Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Raises Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 09, 2025
pulisher
May 09, 2025

Monte Rosa Therapeutics Reports Strong Q1 2025 Earnings - TipRanks

May 09, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics Reports Strong Q1 2025 Results - MSN

May 08, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates - MSN

May 08, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

MONTE ROSA THERAPEUTICS Earnings Results: $GLUE Reports Quarterly Earnings - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics (GLUE) Advances Novel Therapeutic Progra - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Monte Rosa Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 06, 2025

Invesco Ltd. Purchases New Shares in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 06, 2025
pulisher
May 05, 2025

Monte Rosa Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

JPMorgan Chase & Co. Acquires 5,551 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 05, 2025
pulisher
May 04, 2025

Wells Fargo & Company MN Buys 47,952 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 04, 2025

Monte Rosa Therapeutics Inc (GLUE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Monte Rosa Therapeutics Inc 주식 (GLUE) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Leo Chandra P.
Director
Mar 24 '25
Buy
5.84
10,000
58,383
10,000
Versant Venture Capital VI, L.
10% Owner
Oct 28 '24
Sale
9.66
89,990
869,240
2,007,948
Versant Venture Capital VI, L.
10% Owner
Oct 29 '24
Sale
9.16
67,905
621,801
1,573,453
$71.22
price up icon 5.12%
$22.86
price up icon 0.18%
$35.10
price up icon 0.75%
$19.95
price up icon 0.86%
$106.33
price down icon 0.23%
biotechnology ONC
$264.42
price down icon 1.93%
자본화:     |  볼륨(24시간):